Skip to main content

Psilocybin as a Treatment for Chronic Pain in Smokers

The purpose of this study is to understand whether psilocybin therapy is safe and well tolerated in improving chronic pain and increasing motivation to quit smoking for people who have chronic pain and smoke cigarettes. Psilocybin is a psychedelic drug and the active ingredient in "magic mushrooms." Psilocybin is currently being studied in clinical trials but has no current medical use in the United States. Some studies have shown that a dose of psilocybin can help people quit smoking. Other studies have shown that a dose of psilocybin may improve certain chronic pain conditions, such as migraine headaches. We believe that it may also be helpful for people who smoke and have chronic pain, but this has not been tested yet.

Status
planned
Phase
Early Phase 1
Institution
Yale University
Start date
2026-07-01
End date
2027-12-01
Registry ID
NCT07118332

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.